747.84003 USD
7.9449
1.05%
Last update Dec 16, 4:20 PM GMT
Main market
Day range
738.58899
764.98999
Previous close
755.78497
Open
756.69000
Access this stock data via API
Subscribe
Regeneron Pharmaceuticals, Inc.
747.84
7.94
1.05%

Financials

Income statement

Fiscal date Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total reported revenue 7.4M 3.8M 3.3M 6.3M
Cost of revenue
Gross profit
Operating expense
Research & development 20.0M 22.9M 20.0M 26.5M
Selling general and admin 10.3M 10.5M 10.7M 10.6M
Other operating expenses
Operating income -22.9M -29.6M -27.3M -30.8M
Non operating interest income
Income 1.2M 192K 172K 63K
Expense 405K 178K 42K 53K
Other income expense -1.8M -1.4M -952K 8.5M
Pretax income -23.9M -31.0M -28.2M -22.3M
Tax provision
Net income -23.9M -31.0M -28.2M -22.3M
Basic EPS -0.2 -0.5 -0.5
Diluted EPS -0.2 -0.5 -0.5
Basic average shares 110.8M 68.0M 61.0M
Diluted average shares 110.8M 68.0M 61.0M
EBITDA -21.3M -28.6M -25.9M -28.0M
Net income from continuing op. -23.9M -31.0M -28.2M -22.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 4 minutes

09:25
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).